MEGAN SETTLES: Open Payments
NPI 1992008353 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 50 payments from 14 companies in 2025. Trend: 2023 $1,023 · 2024 $1,024 · 2025 $1,171
Food & beverage: $1,004Education: $167
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $247 |
| Janssen Biotech, Inc. | 9 | $228 |
| GENZYME CORPORATION | 8 | $170 |
| LEO Pharma Inc. | 3 | $71 |
| UCB, Inc. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $66 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Lilly USA, LLC | 3 | $51 |
| ABBVIE INC. | 2 | $44 |
Products named: TREMFYA, DUPIXENT, ILUMYA, ADBRY, Bimzelx, Sotyktu, TALTZ, SKYRIZI.
Industry payments across KY — which companies pay providers there.
